Variant report
Variant | nsv471284 |
---|---|
Chromosome Location | chr9:12479157-12513587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:43095234..43095797-chr9:12480274..12480774,2 | MCF-7 | breast: | |
2 | chr9:12495478..12497603-chr9:12499554..12502350,2 | MCF-7 | breast: | |
3 | chr9:12495478..12497603-chr9:12499554..12502350,2 | MCF-7 | breast: | |
4 | chr9:12494239..12495105-chr9:12503977..12504835,2 | MCF-7 | breast: | |
5 | chr9:12494239..12495105-chr9:12503977..12504835,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563697485 | chr9:12483211-12483212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1576659 | chr9:12483221-12483222 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs182100110 | chr9:12483255-12483256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569635995 | chr9:12483262-12483263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535656150 | chr9:12483263-12483264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548877865 | chr9:12483268-12483269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565985871 | chr9:12483275-12483276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534877265 | chr9:12483280-12483281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188295161 | chr9:12483311-12483312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376238736 | chr9:12483324-12483325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150732481 | chr9:12483346-12483347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192575127 | chr9:12483347-12483348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535278630 | chr9:12483378-12483379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139045580 | chr9:12483399-12483400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556649962 | chr9:12483422-12483423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535331082 | chr9:12483467-12483468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370859166 | chr9:12483472-12483473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542429247 | chr9:12483481-12483482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561897756 | chr9:12483504-12483505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572414615 | chr9:12483515-12483516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541365581 | chr9:12483532-12483533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555234975 | chr9:12483541-12483542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147224717 | chr9:12483546-12483547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532978147 | chr9:12483566-12483567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371249785 | chr9:12483583-12483584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373126937 | chr9:12483638-12483639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs117746287 | chr9:12483644-12483645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75314284 | chr9:12483645-12483646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117390514 | chr9:12483687-12483688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543474047 | chr9:12483715-12483716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373429614 | chr9:12483721-12483722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78706333 | chr9:12483734-12483735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571548609 | chr9:12483739-12483740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539835119 | chr9:12483740-12483741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76913899 | chr9:12483767-12483768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117506518 | chr9:12483784-12483785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535536753 | chr9:12483804-12483805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555431870 | chr9:12483829-12483830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185362027 | chr9:12483859-12483860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189892404 | chr9:12483875-12483876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs192631295 | chr9:12483893-12483894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13284853 | chr9:12483917-12483918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10960680 | chr9:12483941-12483942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs184682971 | chr9:12483970-12483971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563100270 | chr9:12483981-12483982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528873780 | chr9:12484042-12484043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58654493 | chr9:12484044-12484045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs397815179 | chr9:12484059-12484060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs370658182 | chr9:12484065-12484066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs62542329 | chr9:12484103-12484104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12483200-12484200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr9:12490600-12491200 | Enhancers | Fetal Heart | heart |
3 | chr9:12493000-12493600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr9:12494200-12495800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr9:12495000-12496000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr9:12495400-12496200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr9:12495800-12496400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr9:12495800-12496400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr9:12496000-12496600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr9:12496800-12497000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr9:12497800-12499000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr9:12503800-12504200 | Enhancers | Fetal Lung | lung |
13 | chr9:12511600-12512800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr9:12511800-12512200 | Enhancers | Fetal Brain Female | brain |
15 | chr9:12512800-12513000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr9:12512800-12513800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr9:12513000-12514200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |